P13569 (CFTR_HUMAN) Homo sapiens (Human)

Cystic fibrosis transmembrane conductance regulator UniProtKBInterProSTRINGInteractive Modelling

1480 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The complex of phosphorylated human delta F508 cystic fibrosis transmembrane conductance regulator …
8eio
 Heteromer
1-1451
2×MG; 2×ATP; 1×CLR; 1×D12; 1×VX8; 1×WJX;
Assess
The complex of phosphorylated human cystic fibrosis transmembrane conductance regulator (CFTR) with…
7svd
 Heteromer
1-1451
2×MG; 2×ATP; 1×D12; 2×D10; 3×CLR; 1×VX8; 1×UNX;
Assess
Complex of ivacaftor with cystic fibrosis transmembrane conductance regulator (CFTR)
6o2p
 Heteromer
1-1451
2×MG; 2×ATP; 6×POV; 1×AJP; 1×VX7;
Assess
Phosphorylated, ATP-bound human cystic fibrosis transmembrane conductance regulator (CFTR)
6msm
 Heteromer
1-1451
2×MG; 2×ATP; 5×POV; 1×CLR;
Assess
Complex of human cystic fibrosis transmembrane conductance regulator (CFTR) and GLPG1837
6o1v
 Heteromer
1-1451
1×LJP; 2×MG; 2×ATP; 5×POV; 1×CLR;
Assess
The complex of phosphorylated human cystic fibrosis transmembrane conductance regulator (CFTR) with…
7sv7
 Heteromer
1-1451
2×MG; 2×ATP; 2×DD9; 4×D12; 2×CLR; 1×C14; 1×PJ8; 1×CV6;
Assess
The complex of dephosphorylated human cystic fibrosis transmembrane conductance regulator (CFTR) an…
7svr
 Heteromer
3-1436
1×VX8;
Assess
Dephosphorylated, ATP-free human cystic fibrosis transmembrane conductance regulator (CFTR)
5uak
 Heteromer
5-1436
Assess
Human NBD1 of CFTR in complex with nanobodies D12 and T4
6gjs
 Heteromer
387-636
2×MG; 1×ATP;
Assess
human NBD1 of CFTR in complex with nanobodies D12 and G3a
6gkd
 Heteromer
389-636
5×GLC; 6×ATP; 10×MG; 2×GOL;
Assess
Human NBD1 of CFTR in complex with nanobodies D12 and T8
6gk4
 Heteromer
390-636
1×GOL; 1×MG; 1×ATP;
Assess
human NBD1 of CFTR in complex with nanobody G11a
6ze1
 Heteromer
423-637
1×ATP; 3×EDO; 1×GOL;
Assess
human NBD1 of CFTR in complex with nanobody T27
6gjq
 Heteromer
443-637
2×ATP;
Assess
human NBD1 of CFTR in complex with nanobodies T2a and T4
6gju
 Heteromer
449-638
1×GOL; 1×PEG;
Assess
Crystal structure of human 14-3-3 gamma in complex with CFTR R-domain peptide pS768-pS795
5d3e
 Heteromer
P61981; 		766-798
Assess
Crystal structure of human 14-3-3 protein beta in complex with CFTR peptide pS753pS768 and PPI stab…
7qi1
 Heteromer
S7N159; 		748-774
2×ARG; 2×Q95; 2×TYR; 2×GLN;
Assess
Crystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768 and stabil…
5d3f
 Heteromer
P63104; 		750-774
1×FSC;
Assess
Crystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768
5d2d
 Heteromer
P63104; 		751-774
2×GLC; 4×CL;
Assess
Crystal structure of human 14-3-3 beta in complex with CFTR R-domain peptide pS753-pS768
6hep
 Heteromer
P31946; 		752-774
1×ETE;
Assess
Crystal structure of filamin-A immunoglobulin-like repeat 21 bound to an N-terminal peptide of CFTR
3isw
 Heteromer
P21333; 		5-22
Assess
PDZ Domain of CAL (Cystic Fibrosis Transmembrane Regulator-Associated Ligand)
2lob
 Heteromer
Q9HD26; 		1473-1480
Assess
Crystal structure of human F508A NBD1 domain with ATP
1xmi
homo-5-mer388-672
5×MG; 5×ATP;
Assess
The complex of phosphorylated human delta F508 cystic fibrosis transmembrane conductance regulator …
8eiq
monomer1-1451
2×MG; 2×ATP; 1×CLR; 1×D12; 1×VX7; 1×WJX; 1×CV6;
Assess
Complex of the phosphorylated human cystic fibrosis transmembrane conductance regulator (CFTR) with…
8ubr
monomer1-1451
2×MG; 2×ATP; 2×LBN; 2×CLR; 1×WG5;
Assess
Dephosphorylated human delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)
8ej1
monomer3-1436
Assess
Dehosphorylated, ATP-bound human cystic fibrosis transmembrane conductance regulator (CFTR)
8fzq
monomer5-1435
2×MG; 2×ATP;
Assess
The complex of phosphorylated human delta F508 cystic fibrosis transmembrane conductance regulator …
8eig
monomer3-1429
2×MG; 2×ATP; 1×CLR; 1×WJX;
Assess
Human NBD1 with Phe508
2bbo
monomer389-676
1×MG; 1×ATP;
Assess
Crystal structure of human deltaF508 human NBD1 domain with ATP
1xmj
monomer391-675
1×MG; 1×ATP;
Assess
Human deltaF508 NBD1 with three solubilizing mutations
2bbs
monomer388-671
1×MG; 1×ATP;
Assess
Human CFTR aa389-678 (NBD1), deltaF508 with three solubilizing mutations, bound ATP
4wz6
monomer389-672
1×ATP; 1×MG;
Assess
Human deltaF508 NBD1 with two solublizing mutations.
2bbt
monomer390-669
1×MG; 1×ATP;
Assess
Minimal human CFTR first nucleotide binding domain as a head-to-tail dimer with delta F508
2pzf
monomer387-646
1×MG; 1×ATP;
Assess
Minimal human CFTR first nucleotide binding domain as a head-to-tail dimer
2pze
monomer387-645
1×MG; 1×ATP;
Assess
Minimal human CFTR first nucleotide binding domain as a monomer
2pzg
monomer390-646
1×MG; 1×ATP; 1×GOL;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tf8
monomer389-638
1×TTP; 1×MG;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfc
monomer389-638
1×MG; 1×GTP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfi
monomer390-638
1×MG; 1×DGT;
Assess
Human CFTR first nucleotide binding domain with dF508/V510D
6wbs
monomer388-635
1×ATP; 1×MG;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfa
monomer390-637
1×DUT; 1×MG;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tgk
monomer390-637
1×MG; 1×DTP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tf7
monomer390-637
1×MG; 1×ATP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfj
monomer390-636
1×MG; 1×DCP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfb
monomer390-636
1×MG; 1×MGP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfd
monomer390-636
1×MG; 1×CTP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tff
monomer390-636
1×MG; 1×UTP;
Assess
Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR)…
5tfg
monomer390-636
1×MG; 1×M5T;
Assess
Crystal structure of nucleotide-binding domain 2 (NBD2) of the human Cystic Fibrosis Transmembrane …
6uk1
monomer1202-1430
1×ATP; 1×MG;
Assess
Crystal structure of human NBD2 complexed with N6-Phenylethyl-ATP (P-ATP)
3gd7
monomer1202-1427
1×B44;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8eio.1.Amonomer0.661-1451
1×MG; 2×ATP; 1×CLR; 1×D12; 1×VX8; 1×WJX;99.93
Assess
6d3r.1.Amonomer0.6342-1439
2×ATP;80.50
Assess
7svr.1.Amonomer0.613-1436
1×VX8;100.00
Assess

5 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28ubr.1.Amonomer0.641-1390
1×MG; 1×ATP; 1×LBN; 2×CLR; 1×WG5;98.10
Assess
Isoform 26d3r.1.Amonomer0.6242-1378
1×ATP;79.13
Assess
Isoform 26ujt.1.Amonomer0.5067-1386
16.82
Assess
Isoform 31r0z.1.Amonomer0.71390-593
1×MG;74.51
Assess
Isoform 38eio.1.Amonomer0.711-604
1×MG; 1×CLR; 1×D12; 1×VX8;98.67
Assess